Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mark Altmeyer Insider Profile
4 Followers
Mark Altmeyer, Pres (ASG) & Chief Comm. Ofc. at Sio Gene Therapies, holds 41.25K shares in Alector (Ticker: ALEC), holds 3.50K shares in Myovant Sciences (Ticker: MYOV), holds 2.30K shares in Sio Gene Therapies (Ticker: SIOX).
Mark Altmeyer Sio Gene Therapies (SIOX)Pres (ASG) & Chief Comm. Ofc.
Sio Gene Therapies (SIOX)
Pres (ASG) & Chief Comm. Ofc.
Ranked #66,726 out of 98,624 Corporate Insiders
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
-20.20%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Mark Altmeyer holds in companies
Most Profitable Insider Trade
Stock:
Sio Gene Therapies
(SIOX)
(SIOX)
Rating:Informative Buy
Date:Mar 14, 2016 - Mar 14, 2017
Return:+21.30%
The most profitable trade made by Mark Altmeyer
Mark Altmeyer's Trading History
Sio Gene Therapies
Mar 14, 2016
―
Informative Buy
25.62K
$1.10K
Myovant Sciences
Jun 15, 2018
―
Informative Buy
46.83K
$94.43K
Alector
Mar 21, 2024
Director
Uninformative Buy
―
$217.80K
List of latest transactions for each holding click on a transaction to see Mark Altmeyer's performance on stock
You May Also Like
Mark Altmeyer insider profile FAQ
What is the percentage of profitable transactions made by Mark Altmeyer?
The percentage of profitable transactions made by Mark Altmeyer is 50%.
What is the average return per transaction made by Mark Altmeyer?
The average return per transaction made by Mark Altmeyer is -20.20%.
What stocks does Mark Altmeyer hold?
Mark Altmeyer holds: SIOX, MYOV, ALEC stocks.
What was Mark Altmeyer’s latest transaction?
Mark Altmeyer latest transaction was an Uninformative Buy of ―.
What was Mark Altmeyer's most profitable transaction?
Mark Altmeyer’s most profitable transaction was an Informative Buy of SIOX stock on March 14, 2016. The return on the trade was 21.30%.
What is Mark Altmeyer's role in Sio Gene Therapies?
Mark Altmeyer's role in Sio Gene Therapies is Pres (ASG) & Chief Comm. Ofc..
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.